Our Laboratory in Jining, China

Step Into Our Jining Facility!

In 2019, CellCarta proudly opened a state-of-the-art CRO laboratory in Jining, China, expanding our global footprint to support the evolving needs of clinical research.

This facility plays a key role in our global CRO network, serving biopharma clients with clinical trial support across Asia.

It is equipped with advanced technologies and offers a comprehensive suite of services designed to deliver high-quality data and reliable results for a variety of scientific and clinical applications.

Watch the video to discover our China laboratory:

Exclusive Services by CellCarta: A Quick Overview

Flow Cytometry Service

Our Jining laboratory is equipped with the latest flow cytometry technologies, including the BD FACSLyric™ and BD LSRFortessa™ platforms. These systems provide advanced capabilities for cell analysis, enabling precise and comprehensive data collection for research and clinical diagnostics.

As a global CRO with extensive flow cytometry expertise, we support exploratory and preclinical research in addition to clinical trials across therapeutic areas.

Immunohistochemistry (IHC) and In Situ Hybridisation (ISH)

We offer robust IHC and ISH services, essential for detailed tissue analysis and molecular diagnostics. Our techniques ensure accurate detection and localization of biomarkers within tissue samples, providing critical insights for various research applications.

Genomic Services

Our genomic services include real-time PCR and NanoString technologies. Real-time PCR allows for precise quantification of nucleic acids, while NanoString offers high-throughput gene expression analysis. These tools are indispensable for genetic research and diagnostics.

These services are offered as part of CellCarta’s broader genomics CRO capabilities, supporting biomarker discovery and companion diagnostics development.

Proteomic and Immunoassay Services

Our Jining laboratory utilizes the Olink® and Meso Scale Discovery (MSD) platforms for advanced proteomic analyses. These technologies facilitate comprehensive protein profiling and biomarker discovery, supporting translational research and clinical studies.

ELISpot (ImmunSpotS6)

We provide ELISpot services using the ImmunSpotS6 system, which is crucial for measuring cellular immune responses at the single-cell level. This technique is widely used in immunology research and vaccine development.

Certifications and Compliance

Our laboratory in Jining has achieved several important certifications, demonstrating our commitment to quality and compliance:

• CAP Inspection: Successfully passed in late 2020.
• Human Genetics Resources Administration of China (HGRAC): Ensures adherence to local genetic resource regulations.
• Biosafety Level 2 Certification: Ensures safe handling of biohazardous materials.
• Import Permits: Allows timely receipt of necessary reagents and specimens for assay qualification and transfer.

These certifications ensure robust compliance and adherence to regulatory standards for clinical studies in China.

Global Reach and Expertise

CellCarta’s global network, including our Jining laboratory, ensures that high-quality sample processing services are accessible worldwide.

Our strategically located facilities and partnerships with local laboratories enable us to provide consistent and reliable services across the globe.

Our local experts ensure we meet all necessary regulatory standards, including supporting HGRAC applications, import and export of samples, and NMPA submissions. 

As a global CRO, we provide region-specific sample logistics, globally standardized SOPs, global assay transfer, and standardized data delivery for multi-site clinical trials.

Why Choose CellCarta?

At CellCarta, we understand the critical importance of every sample. Our dedication to maintaining high standards, combined with innovative solutions and a global reach, sets us apart as a leader in the field of sample processing.

Partner with CellCarta- a trusted CRO in China to access advanced immunology, genomics, and biomarker platforms for regional and global clinical trials.

Learn more about our offerings at our site in Jining, China